MedTrace Logo

Dexmedetomidine an Effective Drug in Reducing Anesthetic Requirements in External Dacrocystorhinostomy (DCR) Patients

NCT06808295 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-02-05

No results posted yet for this study

Summary

Assessing the intra and postoperative hemodynamic stability in patients undergoing external dacrocystorhinostomy under general anesthesia using Dexmedetomidine as a preoperative sedation compared to traditional technique with intraoperative analgesia and assessing decreased anesthetic requirements intra and postoperative

Conditions

  • Patients Undergoing External Dacrocystorhinostomy Operations
  • Assess Decreased Anesthetic Requirements Intraoperative

Interventions

DRUG

Dexmedetomidine Hydrochloride

drug will be given before induction and anesthetic doses and hemodynamics will be assessed pre- intra and postoperative

Sponsors & Collaborators

  • Research Institute of Ophthalmology, Egypt

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-16
Primary Completion
2025-04-20
Completion
2025-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06808295 on ClinicalTrials.gov